US Stock MarketDetailed Quotes

Avadel Pharmaceuticals (AVDL)

Watchlist
  • 21.535
  • +0.005+0.02%
Trading Jan 23 11:00 ET
2.11BMarket Cap0.00P/E (TTM)

Avadel Pharmaceuticals (AVDL) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
54.86%77.47M
64.15%68.13M
93.21%52.51M
504.79%169.12M
159.14%50.41M
613.22%50.03M
2,674.33%41.5M
27.18M
27.96M
19.45M
Operating revenue
54.86%77.47M
64.15%68.13M
93.21%52.51M
504.79%169.12M
159.14%50.41M
613.22%50.03M
2,674.33%41.5M
--27.18M
--27.96M
--19.45M
Cost of revenue
-166.87%-4.12M
128.34%6.37M
266.43%5.58M
1,705.79%15.28M
594.37%4.81M
5,160.68%6.16M
7,644.44%2.79M
1.52M
846K
693K
Gross profit
85.97%81.58M
59.53%61.76M
82.94%46.93M
467.32%153.84M
143.06%45.6M
536.07%43.87M
2,551.78%38.72M
25.66M
27.12M
18.76M
Operating expense
80.21%79.65M
2.76%52.88M
-3.40%49.94M
18.96%196.24M
11.99%48.9M
5.21%44.2M
0.89%51.46M
82.67%51.69M
73.25%164.97M
88.06%43.66M
Selling and administrative expenses
30.31%52.64M
2.57%48.62M
-6.26%45.58M
19.34%181.04M
8.04%44.62M
3.16%40.39M
1.34%47.41M
98.72%48.62M
103.59%151.71M
143.22%41.3M
Research and development costs
610.23%27.01M
5.04%4.26M
41.92%4.35M
14.59%15.2M
81.18%4.27M
33.49%3.8M
-4.07%4.05M
-19.90%3.07M
-35.94%13.26M
-62.17%2.36M
Operating profit
692.35%1.94M
169.73%8.88M
88.47%-3M
69.24%-42.4M
86.76%-3.3M
99.07%-327K
74.28%-12.74M
8.00%-26.04M
-44.78%-137.85M
-7.25%-24.9M
Net non-operating interest income expense
14.36%-2.42M
13.29%-2.36M
13.66%-2.24M
-9.55%-10.83M
-14.78%-2.7M
-42.57%-2.82M
-18.34%-2.72M
20.47%-2.59M
19.90%-9.89M
27.68%-2.35M
Non-operating interest expense
-14.36%2.42M
-13.29%2.36M
-13.66%2.24M
9.55%10.83M
14.78%2.7M
42.57%2.82M
18.34%2.72M
-20.47%2.59M
-19.90%9.89M
-27.68%2.35M
Other net income (expense)
-12.79%532K
-103.02%-34K
-71.19%397K
131.82%4.15M
163.48%1.04M
-32.45%610K
109.00%1.13M
613.99%1.38M
-236.05%-13.04M
-82.55%-1.63M
Gain on sale of security
-12.79%532K
-103.02%-34K
-71.19%397K
4,670.11%4.15M
163.48%1.04M
-32.45%610K
80.74%1.13M
613.99%1.38M
116.23%87K
-52.24%-1.63M
Special income (charges)
----
----
----
--0
--0
--0
--0
----
-292.50%-13.13M
--0
-Less:Restructuring and merger&acquisition
----
----
----
--0
----
----
----
----
--0
----
-Less:Other special charges
----
----
----
----
----
----
----
----
--13.13M
--0
Income before tax
102.13%54K
145.32%6.5M
82.23%-4.84M
69.47%-49.08M
82.82%-4.96M
92.99%-2.54M
77.73%-14.33M
13.12%-27.25M
-44.27%-160.78M
-5.56%-28.89M
Income tax
-61.36%34K
-522.79%-3.17M
-16.13%78K
50.70%-247K
180.00%80K
-1.12%88K
-665.56%-509K
116.03%93K
-101.93%-501K
-217.65%-100K
Net income
100.76%20K
169.92%9.67M
82.01%-4.92M
69.53%-48.83M
82.48%-5.04M
92.76%-2.63M
78.55%-13.82M
11.18%-27.34M
-16.59%-160.28M
-4.87%-28.79M
Net income continuous Operations
100.76%20K
169.92%9.67M
82.01%-4.92M
69.53%-48.83M
82.48%-5.04M
92.76%-2.63M
78.55%-13.82M
11.18%-27.34M
-16.59%-160.28M
-4.87%-28.79M
Minority interest income
Net income attributable to the parent company
100.76%20K
169.92%9.67M
82.01%-4.92M
69.53%-48.83M
82.48%-5.04M
92.76%-2.63M
78.55%-13.82M
11.18%-27.34M
-16.59%-160.28M
-4.87%-28.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
100.76%20K
169.92%9.67M
82.01%-4.92M
69.53%-48.83M
82.48%-5.04M
92.76%-2.63M
78.55%-13.82M
11.18%-27.34M
-16.59%-160.28M
-4.87%-28.79M
Basic earnings per share
0
171.43%0.1
83.33%-0.05
74.50%-0.51
82.76%-0.05
92.68%-0.03
83.13%-0.14
37.50%-0.3
12.66%-2
34.09%-0.29
Diluted earnings per share
0
171.43%0.1
83.33%-0.05
74.50%-0.51
82.76%-0.05
92.68%-0.03
83.13%-0.14
37.50%-0.3
12.66%-2
34.09%-0.29
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 54.86%77.47M64.15%68.13M93.21%52.51M504.79%169.12M159.14%50.41M613.22%50.03M2,674.33%41.5M27.18M27.96M19.45M
Operating revenue 54.86%77.47M64.15%68.13M93.21%52.51M504.79%169.12M159.14%50.41M613.22%50.03M2,674.33%41.5M--27.18M--27.96M--19.45M
Cost of revenue -166.87%-4.12M128.34%6.37M266.43%5.58M1,705.79%15.28M594.37%4.81M5,160.68%6.16M7,644.44%2.79M1.52M846K693K
Gross profit 85.97%81.58M59.53%61.76M82.94%46.93M467.32%153.84M143.06%45.6M536.07%43.87M2,551.78%38.72M25.66M27.12M18.76M
Operating expense 80.21%79.65M2.76%52.88M-3.40%49.94M18.96%196.24M11.99%48.9M5.21%44.2M0.89%51.46M82.67%51.69M73.25%164.97M88.06%43.66M
Selling and administrative expenses 30.31%52.64M2.57%48.62M-6.26%45.58M19.34%181.04M8.04%44.62M3.16%40.39M1.34%47.41M98.72%48.62M103.59%151.71M143.22%41.3M
Research and development costs 610.23%27.01M5.04%4.26M41.92%4.35M14.59%15.2M81.18%4.27M33.49%3.8M-4.07%4.05M-19.90%3.07M-35.94%13.26M-62.17%2.36M
Operating profit 692.35%1.94M169.73%8.88M88.47%-3M69.24%-42.4M86.76%-3.3M99.07%-327K74.28%-12.74M8.00%-26.04M-44.78%-137.85M-7.25%-24.9M
Net non-operating interest income expense 14.36%-2.42M13.29%-2.36M13.66%-2.24M-9.55%-10.83M-14.78%-2.7M-42.57%-2.82M-18.34%-2.72M20.47%-2.59M19.90%-9.89M27.68%-2.35M
Non-operating interest expense -14.36%2.42M-13.29%2.36M-13.66%2.24M9.55%10.83M14.78%2.7M42.57%2.82M18.34%2.72M-20.47%2.59M-19.90%9.89M-27.68%2.35M
Other net income (expense) -12.79%532K-103.02%-34K-71.19%397K131.82%4.15M163.48%1.04M-32.45%610K109.00%1.13M613.99%1.38M-236.05%-13.04M-82.55%-1.63M
Gain on sale of security -12.79%532K-103.02%-34K-71.19%397K4,670.11%4.15M163.48%1.04M-32.45%610K80.74%1.13M613.99%1.38M116.23%87K-52.24%-1.63M
Special income (charges) --------------0--0--0--0-----292.50%-13.13M--0
-Less:Restructuring and merger&acquisition --------------0------------------0----
-Less:Other special charges ----------------------------------13.13M--0
Income before tax 102.13%54K145.32%6.5M82.23%-4.84M69.47%-49.08M82.82%-4.96M92.99%-2.54M77.73%-14.33M13.12%-27.25M-44.27%-160.78M-5.56%-28.89M
Income tax -61.36%34K-522.79%-3.17M-16.13%78K50.70%-247K180.00%80K-1.12%88K-665.56%-509K116.03%93K-101.93%-501K-217.65%-100K
Net income 100.76%20K169.92%9.67M82.01%-4.92M69.53%-48.83M82.48%-5.04M92.76%-2.63M78.55%-13.82M11.18%-27.34M-16.59%-160.28M-4.87%-28.79M
Net income continuous Operations 100.76%20K169.92%9.67M82.01%-4.92M69.53%-48.83M82.48%-5.04M92.76%-2.63M78.55%-13.82M11.18%-27.34M-16.59%-160.28M-4.87%-28.79M
Minority interest income
Net income attributable to the parent company 100.76%20K169.92%9.67M82.01%-4.92M69.53%-48.83M82.48%-5.04M92.76%-2.63M78.55%-13.82M11.18%-27.34M-16.59%-160.28M-4.87%-28.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 100.76%20K169.92%9.67M82.01%-4.92M69.53%-48.83M82.48%-5.04M92.76%-2.63M78.55%-13.82M11.18%-27.34M-16.59%-160.28M-4.87%-28.79M
Basic earnings per share 0171.43%0.183.33%-0.0574.50%-0.5182.76%-0.0592.68%-0.0383.13%-0.1437.50%-0.312.66%-234.09%-0.29
Diluted earnings per share 0171.43%0.183.33%-0.0574.50%-0.5182.76%-0.0592.68%-0.0383.13%-0.1437.50%-0.312.66%-234.09%-0.29
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More